HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF

HUTCHMED (China) Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026

$14.18+0.13 (+0.93%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 27.3
Dividend yield: –

HUTCHMED (China) Ltd balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	71	154	284	313	378	236	121	86	85	79	32	39	47
Short-Term Investments	1,296	682	603	318	634	200	96	215	273	24	0	–	–
Cash & Short-Term Investments	1,367	836	886	631	1,012	435	217	301	358	104	32	39	47
Receivables	127	156	117	98	84	48	41	40	38	41	33	–	–
Inventory	41	50	50	57	36	20	16	12	12	13	9.56	–	–
Prepaid Expenses & Other	8.34	7.92	7.11	22	14	7.04	3.77	4.25	2.57	0.70	–	–	–
Other Current Assets	–	–	–	–	–	–	–	17	–	1.51	–	–	–
Total Current Assets	1,567	1,067	1,097	840	1,212	531	317	371	432	167	90	–	–
Property, Plant & Equipment	95	92	100	76	41	24	21	17	14	9.95	8.51	–	–
Gross Property, Plant & Equipment	168	152	146	113	74	50	44	36	32	24	22	–	–
Accumulated Depreciation	–	–	–	-37	-33	-26	-23	-20	-17	-14	-13	-13	–
Equity Method Investments	11	78	48	74	76	140	99	138	144	159	120	–	–
Operating Lease Right-of-Use Assets	3.03	4.50	4.67	8.72	12	8.02	5.52	5.75	–	–	–	–	–
Goodwill	3.11	2.99	3.06	3.14	3.38	3.31	3.11	3.19	3.31	3.14	3.33	3.43	0.41
Intangible Assets	8.94	–	0.02	0.09	0.16	0.23	0.28	0.35	0.43	0.47	0.57	–	–
Deferred Tax Assets	13	12	15	15	9.40	1.52	0.82	0.58	–	–	–	–	–
Other Long-Term Assets	39	12	15	16	22	20	5.78	6.64	6.65	6.60	–	–	–
Total Assets	1,753	1,274	1,280	1,029	1,373	724	465	532	598	342	230	–	–
Accounts Payable	46	43	36	71	41	32	24	26	24	36	21	–	–
Short-Term Debt	25	23	31	–	–	–	–	–	–	–	–	–	–
Current Portion of Long-Term Debt	25	23	31	–	27	–	–	–	30	20	–	–	–
Current Debt	50	47	62	–	27	–	–	–	30	20	–	–	–
Current Portion of Leases	2.88	2.93	3.93	3.71	4.92	2.79	3.22	–	–	–	–	–	–
Current Income Taxes Payable	2.08	1.55	2.58	1.11	16	1.12	1.83	0.56	0.98	0.27	0.44	0.11	–
Deferred Revenue (Current)	31	50	58	13	12	1.60	2.11	2.54	1.30	0.96	1.17	–	–
Other Current Liabilities	4.96	2.02	2.16	2.10	17	4.38	4.30	27	–	2.60	–	–	–
Total Current Liabilities	316	377	403	354	312	158	113	85	105	95	81	–	–
Long-Term Debt	68	59	48	18	–	27	27	27	–	27	27	–	–
Long-Term Leases	1.85	4.09	2.86	5.20	7.16	6.06	3.05	–	–	–	–	–	–
Operating Lease Liabilities	4.73	7.01	6.79	8.90	12	8.85	6.27	6.36	–	–	–	–	–
Deferred Tax Liabilities	0.26	2.99	1.48	2.71	2.77	5.06	3.16	–	4.45	4.00	3.42	–	–
Other Long-Term Liabilities	–	18	11	12	12	8.78	5.96	2.40	1.12	8.13	10	–	–
Total Liabilities	502	502	536	393	333	205	152	120	113	138	127	–	–
Total Debt	118	106	110	18	27	27	27	27	30	47	27	–	–
Common Stock	87	87	87	86	86	73	67	67	66	61	57	–	–
Additional Paid-In Capital	1,534	1,518	1,522	1,497	1,505	822	515	506	497	208	114	–	–
Retained Earnings	-379	-833	-871	-971	-610	-416	-290	-183	-107	-80	-92	–	–
Treasury Stock	–	–	–	–	–	–	–	–	–	-2.39	-1.79	–	–
Comprehensive Income & Other	-4.53	-12	-8.16	-1.90	5.57	4.48	-3.85	-0.24	5.43	-4.28	5.02	–	–
Shareholders' Equity	1,238	760	731	610	987	484	288	389	462	184	83	–	–
Noncontrolling Interest	13	12	13	27	53	35	25	23	23	20	19	–	–
Total Equity	1,251	772	743	637	1,040	519	313	412	484	204	102	57	78
Total Liabilities & Equity	1,753	1,274	1,280	1,029	1,373	724	465	532	598	342	230	–	–
Deposits	1.68	1.63	1.56	3.62	2.11	1.41	1.78	1.23	1.28	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 38.7%
Operating margin: -7.1%
Net margin: 83.3%
Return on equity, FY2025: 45.7%

Financial strength

Current ratio: 5.64
Debt to equity: 0.09
Debt to assets: 6.7%
Cash to current liabilities: 38.7%

Valuation

P/E ratio: 27.3
Price to sales: –
Price to book: –
Dividend yield: –